Get started
iShares Biotechnology ETFiShares Biotechnology ETFiShares Biotechnology ETF

iShares Biotechnology ETF

No trades
See on Supercharts
Overview Analysis News
Ideas
Discussions Technicals Seasonals Options

IBB trade ideas

IBB Short?Looking at following Ken Tester short advice on the IBB, am I crazy? I see a historic growth pattern in Q1 but it does appear to have a dip upcoming in this trend. With the IBB having a near total North American fund it is exposed to political developments such as the shutdown, a new bill to lower prescription drug costs put forth by democrats in the house and with pharmaceuticals companies recent price increases, it seems like a legal battle brewing. I am anticipating a drop to retest it's Christmas woes below 89. Any thoughts? IBB
NASDAQ:IBBShort
by Jonathan78
sell overbought biotechnology sector IBBIBB is up 22% in 20 days. I believe this is unsustainable in the near term (next 2-4 weeks) and believe the stock should retrace. Right now we are testing last highs and should be a good entry place for a quick short term trade. To give myself a little buffer, I am selling the stock for a break even at $112.91 by selling the 112 call/buying 115 call for 91$ per contract. If the stock stays below 112$, my option will expire profitable for 91$ within the next 30 days.
NASDAQ:IBBShort
by TheBulltrader
IBB - Short for now but bullish longer termYet again (markets really are at a critical juncture imo) I can see two possible counts for this index/etf. The red count would suggest a much deeper and longer correction before continuing upwards while the blue count suggests that the rally from June, 2016 was in fact a wave 1 up. Something the blue count does have going for it is that the larger wave 2 correction was already a 4 year correction from 2004 to 2008 so perhaps this wave 4 has been much shorter. I'm leaning with the more bullish blue count. (As it is a longer term chart I have used the fib channel tool for my fib retracements as it apparently a workaround for a lack of proper logarithmic scaling in TradingView.)
NASDAQ:IBBShort
by tomj2417
NASDAQ Biotech ETF (IBB) - Bullish Breakout Options TradeOn Friday's Options Action, the crew analyzed the performance of the biotech sector. The NASDAQ Biotech ETF (IBB) that tracks the large cap names have underperformed the overall sector recently. IBB has recently formed both a long term cup & handle formation and an inverted head & shoulders, a bullish setup. Coupled the largest 5 names in this ETF reporting earnings this week, provides a potential catalyst for the ETF to break higher. Expecting IBB to breakout to the upside, Michael Khouw suggests buying a Sept 113/119/125 Call Spread Risk Reversal for a $0.70 Debit. As of Friday's close, this spread is trading at $0.65. We've structured this trade in OptionsPlay so you can analyze and view this trade along with the supporting technical chart at your convenience. View this OptionsPlay on IBB - app.optionsplay.com Cost: $65 Max Reward: $535 Max Risk: $11,365 POP: 43.18% Breakeven: $119.65 Days to Expiry: 61
NASDAQ:IBBLong
by OptionsPlay